2026 · 2nd Quarter (Apr 1 - June 30)
Filed by THE NICKLES GROUP, LLC.
Open official filingSource-reported fields
Literal source text
Implementation of drug pricing provisions related to H.R. 5376 (P.L. 117-169), The Inflation Reduction Act. Issues related to safe mobility. Issues related to payment for prescription drugs. Issues concerning drug shortages.
Literal federal measure citations: H.R. 5376
Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes. Monitor issues related to OECD Pillar 2.
Literal federal measure citations: H.R. 1
Monitored issues related to pharmaceutical prices. Issues regarding the pharmaceutical and medical device supply chain. Monitored issues concerning drug shortages. Issues concerning the reauthorization of Pandemic and All-Hazards Preparedness and Response Act (PAHPA). Monitored AI issues. Cybersecurity issues and S. 4939, Countering CCP Act. Issues concerning emergency preparedness and essential medical supplies. Issues concerning regulatory reforms.
Literal federal measure citations: S. 4939
Issues related to tariffs.
H.R. 8800 / S. 4784, the FY27 National Defense Authorization Act, as it relates to right to repair, and the ability of government contractors to pay dividends and buy back stock.
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
